Breast Cancer Foundation NZ
New sugar-based drug to stop breast cancer spreading
June 2017
Research Grant
What is the problem and who is affected?
Scientists have identified an enzyme called heparanase that causes breast cancers to spread. But the cost of producing an anti-heparanase drug that’s safe for breast cancer patients is exorbitant – $380,000 per gram!
What is this research hoping to achieve?
Dr Olga Zubkova and her team of carbohydrate chemists at Victoria University’s Ferrier Institute have figured out a much simpler design for a safe anti-heparanase drug – it could cost a thousand times less! We’re giving her $100,000 to investigate this new drug as part of the five-year BCFNZ Ferrier Breast Cancer Research Programme.
-
JuneResearch Grant
Helping surgeons accurately locate breast tumours
-
JuneResearch Grant
New sugar-based drug to stop breast cancer spreading
-
JuneResearch Grant
A personalized vaccine for breast cancer
-
JuneResearch Grant
A simpler way to check for the spread of breast cancer
-
JuneResearch Grant
A new way to treat breast cancers
-
AprilResearch Grant
Development of inhibitors as anti-cancer therapeutics
-
AprilResearch Grant
The potential of immunotherapy as a treatment for ER+ breast cancer
-
AprilResearch Grant
Targeting growth hormone signal transduction in breast cancer
-
MarchResearch Grant
Five-year research partnership targets breast cancer vaccine
-
FebruaryBelinda Scott Fellowship
Benefits of an integrated tai chi programme in breast cancer